Drug sensitivity profiling identifies potential therapies for lymphoproliferative disorders with overactive JAK/STAT3 signaling.
about
Drug sensitivity profiling identifies potential therapies for lymphoproliferative disorders with overactive JAK/STAT3 signaling.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh
2017年學術文章
@zh-hant
name
Drug sensitivity profiling ide ...... veractive JAK/STAT3 signaling.
@en
Drug sensitivity profiling ide ...... veractive JAK/STAT3 signaling.
@nl
type
label
Drug sensitivity profiling ide ...... veractive JAK/STAT3 signaling.
@en
Drug sensitivity profiling ide ...... veractive JAK/STAT3 signaling.
@nl
prefLabel
Drug sensitivity profiling ide ...... veractive JAK/STAT3 signaling.
@en
Drug sensitivity profiling ide ...... veractive JAK/STAT3 signaling.
@nl
P2093
P2860
P50
P356
P1433
P1476
Drug sensitivity profiling ide ...... veractive JAK/STAT3 signaling.
@en
P2093
Alun Parsons
Arjan J van Adrichem
Bhagwan Yadav
Caroline A Heckman
Hanna Rajala
Heikki Kuusanmäki
Olli Dufva
P2860
P304
97516-97527
P356
10.18632/ONCOTARGET.22178
P407
P577
2017-10-31T00:00:00Z